PW

Pawan Walia

Active Director Director DIN 08796958
DIN 08796958 First appointment Jul 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Pawan Walia

Data last updated:

Pawan Walia is a Director at Medicaliber Pharmaceutical Private Limited (since 2020). The company operates in Pharma. Medicaliber Pharmaceutical Private Limited reported revenue of ₹5.6 Lakh (FY 2021).

DIN 08796958
Primary Designation Director
Industry Pharma
First Appointment 17 Jul 2020
Oldest Company Age 6 yrs
Largest company Medicaliber Pharmaceutical Private Limited · ₹5.6 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jul 20202020₹5.6 Lakh (FY 2021)Active

Board colleagues of Pawan Walia

Directorship timeline

Open interactive timeline →
Medicaliber Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Pawan Walia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Walia

Pawan Walia currently holds 1 directorship: Medicaliber Pharmaceutical Private Limited (Director, since 17 Jul 2020, revenue ₹5.6 Lakh (FY 2021)).

Pawan Walia was first appointed on 17 Jul 2020 as Director at Medicaliber Pharmaceutical Private Limited.

The current boards of Pawan Walia's companies include Shivendra Kumar (Medicaliber Pharmaceutical Private Limited), Vikas Gupta (Medicaliber Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available